technetium tc 99m sestamibi has been researched along with Cardiometabolic Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berman, DS; Friedman, J; Gransar, H; Hayes, S; Kang, X; Miranda-Peats, R; Polk, D; Rozanski, A; Shaw, L; Wong, ND | 1 |
| Kinoshita, M; Matsumoto, T; Matsuo, S; Nakamura, Y; Takahashi, M | 1 |
2 other study(ies) available for technetium tc 99m sestamibi and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Metabolic syndrome and diabetes are associated with an increased likelihood of inducible myocardial ischemia among patients with subclinical atherosclerosis.
Topics: Analysis of Variance; Arteriosclerosis; Calcium; Diabetes Complications; Exercise Test; Female; Humans; Male; Metabolic Syndrome; Middle Aged; Myocardial Ischemia; Probability; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; United States | 2005 |
Detection of coronary microvascular disease by means of cardiac scintigraphy.
Topics: Aged; Cardiac Catheterization; Chest Pain; Drug Therapy, Combination; Echocardiography; Electrocardiography; Female; Follow-Up Studies; Humans; Isosorbide Dinitrate; Metabolic Syndrome; Perindopril; Pravastatin; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2002 |